BEIJING, June 29 /PRNewswire-Asia/ -- RainEarth Inc. (OTC Bulletin Board: RNER; "the Company"), announced today that the Company’s Chinese subsidiary, Beijing Rain and Earth Technology Development Corp. Ltd. ("China RainEarth") attended the Fourth session of Marketing Forum for Medicine and Health Products.
A good marketing strategy can be crucial in today’s economy for medicine and health products. In the forum, participants explored various marketing strategies and China RainEarth introduced its marketing network.
Headquartered in the Chinese capital of Beijing and with an office in Shanghai, host of the upcoming 2010 Expo, China RainEarth has signed marketing agreements with a number of companies. HangZhou LongRun Technology Corp. Ltd. assists China RainEarth in recruiting sales distribution agents in Eastern and Southern China for DX Multifunction Blood Purifier and Blood Dialyzers. BallYa International Corp. Ltd., an experienced Import and Export Company, will assist China RainEarth in exploring the international market.
China RainEarth has also signed a partnership agreement with Beijing JiaHua RiSheng Biotechnology Corp. Ltd., which provides blood purifying services at the "Blood Purifying Center". China RainEarth also has partnership with Taiyuan PuKang Hospital as well as Beijing Plasma Science & Technology Studio. Well known experts and an experienced care team from these partners will also assist China RainEarth to keep up with the state of the art technology and distributing the dialysis equipment across the nation.
As Zhu, Yong Fu, CEO of the Company states, "Attending the Fourth session of Marketing Forum for Medicine and Health Products means that China RainEarth will continue to expand its business and stay at the forefront of marketing and technological innovation."
About the Company
RainEarth Inc. (formerly Gold Rock Resources Inc., the "Company") was incorporated in the State of Nevada on March 14, 2006. The Company is a developing stage company that initially engages in the search for mineral deposits or reserves.
On March 25, 2009, the Company and China RainEarth, a company organized and existing under the laws of the People’s Republic of China, entered into a Business Cooperation Agreement (the "Agreement") for a term of twenty years. The purpose of the Agreement is to jointly conduct Hollow Fiber Membrane Materials’ application and manufacturing business in China (the "Business"). The first product that utilizes this technology is blood dialyzer.
The Company will provide Advice and assistance relating to development of marketing and consultancy services, particularly as related to the Business. China RainEarth will give 60% of its revenue after deduction of direct operating costs, expenses and taxes to the Company in consideration of the Company’s services.
Forward-looking statements
This press release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. Forward-looking statements involve risks and uncertainties including, but not limited to, economic and political factors; developments of the Chinese and North American markets and changes in regulatory matters; our business strategies and future plans of operations; the market acceptance and amount of sales of our products and services; our historical losses; the competitive environment within the industries in which we compete; and our ability to raise additional capital, currently needed for expansion. The Company cautions that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements due to several important factors.
For more information, please contact:
RainEarth Inc.
Public Relationship Department
Tel: +852-3005-7220
Email: Investor@rainearth.net
